Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
Current Medical Research and Opinion|May 17, 2018
Initial combination therapy with vildagliptin plus metformin in drug-naïve patients with T2DM: a 24-week real-life study from AsiaManoj Chawla, Tae Ho Kim, Roberto C Mirasol, et al.
Nature Medicine|May 25, 2023
Tirzepatide versus insulin glargine as second-line or third-line therapy in type 2 diabetes in the Asia-Pacific region: the SURPASS-AP-Combo trialLeili Gao, Byung Wan Lee, Manoj Chawla, et al.
Cureus|June 24, 2024
Retrospective Observational Study on Assessing Sitagliptin and Dapagliflozin as a Fixed-Dose Combination in the Indian Population With Type 2 Diabetes Mellitus: The SIDAXA StudyManoj Chawla, Dharmarajan Panneerselvam, Abhay Gundgurthy, et al.
Indian Journal of Endocrinology and Metabolism|January 9, 2023
First-in-Class Oral Semaglutide: Overcoming Barriers of Incretinisation in the Indian ContextRajesh Rajput, Sujoy Ghosh, Samar Banerjee, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|May 20, 2025
Expert Opinion on Optimizing Suboptimal Basal Insulin Titration in India: Addressing Challenges and Leveraging Digital SolutionsSanjay Kalra, Pramila Kalra, Kalyan Kumar Gangopadhyay, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|January 27, 2023
Expert Consensus Recommendations on Time in Range for Monitoring Glucose Levels in People with Diabetes: An Indian PerspectiveViswanathan Mohan, Shashank Joshi, Ambrish Mithal, et al.
The Journal of the Association of Physicians of India|October 14, 2016
Use of Retrospective Continuous Glucose Monitoring for Optimizing Management of Type 2 Diabetes in IndiaViswanathan Mohan, Sunil Jain, Jothydev Kesavadev, et al.
Cureus|January 14, 2026
Expert Opinion of Empagliflozin Positioning in the Current Type 2 Diabetes Mellitus (T2DM) Landscape in Indian PatientsBipin Sethi, Ashwani Mehta, Arundhati Dasgupta, et al.
The Journal of the Association of Physicians of India|June 25, 2023
Intermittent Use of Continuous Glucose Monitoring: A New Paradigm in Treatment of Type 2 DiabetesBanshi Saboo, Ranjit Unnikrishnan, Jothydev Kesavadev, et al.
Indian Journal of Endocrinology and Metabolism|November 22, 2016
Forum for Injection Technique 2.0 Addendum 1: Insulin use in indoor settingsSanjay Kalra, Hemraj B Chandalia, Manoj Chawla, et al.
Pageof 5